Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2008, Vol. 9 Issue (6): 506-510    DOI: 10.1631/jzus.B0820047
Biomedicine     
Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy
Xing-guo ZHANG, Jing MIAO, Min-wei LI, Sai-ping JIANG, Fu-qiang HU, Yong-zhong DU
Department of Pharmacy, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; State Key Lab for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310003, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Herein, solid lipid nanoparticles (SLN) were proposed as a new drug delivery system for adefovir dipivoxil (ADV). The octadecylamine-fluorescein isothiocynate (ODA-FITC) was synthesized and used as a fluorescence maker to be incorporated into SLN to investigate the time-dependent cellular uptake of SLN by HepG2.2.15. The SLN of monostearin with ODA-FITC or ADV were prepared by solvent diffusion method in an aqueous system. About 15 wt% drug entrapment efficiency (EE) and 3 wt% drug loading (DL) could be reached in SLN loading ADV. Comparing with free ADV, the inhibitory effects of ADV loaded in SLN on hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA levels in vitro were significantly enhanced.

Key wordsAdefovir dipivoxil (ADV)      Solid lipid nanoparticles (SLN)      Octadecylamine-fluorescein isothiocynate (ODA-FITC)      Hepatitis B virus (HBV)     
Received: 16 February 2008     
CLC:  R512.6+2  
  R943  
  R978.7  
Cite this article:

Xing-guo ZHANG, Jing MIAO, Min-wei LI, Sai-ping JIANG, Fu-qiang HU, Yong-zhong DU. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 506-510.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B0820047     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2008/V9/I6/506

[1] Jing-yao Pang, Kui-jun Zhao, Jia-bo Wang, Zhi-jie Ma, Xiao-he Xiao. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 533-539.
[2] Yong MAO, Xin HUANG, Ke YU, Hai-bin QU, Chang-xiao LIU, Yi-yu CHENG. Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 474-481.